UTHR | United TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$601.32
+$5.19 (+0.87%)

United Therapeutics (UTHR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Sep 2026, but the two have been closing on each other and a golden cross is projected within 10 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $601.32 vs 50 $530.53 / 200 $532.84
Projection
Golden cross projected in 3 bars
Test
No active test
Last cross
Death cross 10 Sep 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $598.72 vs 50 $523.26 / 200 $348.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 28 Dec 2020 ยท projected 25 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $600.52 vs 50 $560.86 / 200 $531.39
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Oct 2026 ยท projected 30 bars out

Cross history

31
crosses on record since 2017
16 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Oct 2026Golden4-hour30 bars outNot tested
10 Sep 2026Death moderatedaily21 bars outNot tested
10 Jul 2026Death4-hour20 bars out2 bar cross test
18 Sep 2025Golden steepdaily14 bars outNot tested
18 Aug 2025Golden4-hour19 bars outโ€”

About UTHR

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$288M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.